Denta

Quick links to important sections

Denta

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Denta

What is Denta? (Enhanced Overview)

Property Description
Active ingredient Camphor, Chloral Hydrate
Form Solution (Topical Preparation)
Pharmacological class Local Anesthetic, Antiseptic
Common purpose Temporary relief of odontalgia (dental pain)
Origin Synthetic

Denta: Definition and Pharmacological Classification

The Denta preparation is a combined drug formulation utilized in dental medicine, categorized as a Local Anesthetic and Antiseptic solution. Its primary purpose is to provide temporary relief of odontalgia (dental pain) by exerting a rapid, localized effect. This particular combination is clinically recognized for its fast-acting, symptomatic relief in cases of acute, localized dental pain. The preparation is intended exclusively for topical application as a supportive measure against localized discomfort, focusing its action directly at the site of pain. Based on its components, the formulation is characterized as a preparation providing surface action to ease localized irritation.


Composition, Form, and Origin: Camphor and Chloral Hydrate

The Denta preparation is a synthetic compound containing the active ingredients Camphor (Bornan-2-one) and Chloral Hydrate (2,2,2-trichloroethane-1,1-diol). This medicine is supplied as a liquid solution, which is the precise dosage form for its specific topical application. The presence of Camphor imparts a distinguishing characteristic, as it serves both as an active ingredient and as a permeation enhancer, assisting in the absorption and localized effect of the formulation. The two core components are typically dissolved within a stabilizing hydroalcoholic or oily vehicle to ensure chemical stability and facilitate targeted delivery.


Mechanism and General Purpose

The preparation achieves its local analgesic effect primarily through nerve ending desensitization at the treatment site. This action involves the active substances directly influencing the sensory nerves, which temporarily reduces their ability to transmit pain signals. Simultaneously, the Camphor component provides a powerful counterirritant effect, often perceived as a topical cooling effect, which aids in diverting the sensory focus from the underlying discomfort. The overall purpose of this mechanism is to offer swift, localized comfort to dental patients while awaiting necessary professional procedures.

What side effects are possible with Denta?

Possible Side Effects and Safety Information

The safety profile for Denta, a topical preparation containing Camphor and Chloral Hydrate, is based on the official adverse event classifications and high-level safety constraints documented by government regulatory authorities.

Documented Adverse Reactions

Adverse effects are officially categorized by frequency and system-organ class. Common effects may involve Gastrointestinal Disorders such as nausea, vomiting, or stomach pain, and Nervous System Disorders that include drowsiness and headache. Localized effects like skin irritation and rash are also documented.

Less common documented reactions include clumsiness (ataxia), dizziness, and lightheadedness. Serious adverse reactions are associated primarily with the Chloral Hydrate component, including the potential for severe effects on the Cardiac system, such as arrhythmias or QTc prolongation, and Respiratory depression.

Regulatory Safety Constraints

The official labeling defines several safety restrictions and conditions that preclude the use of this medicine:

  • Contraindications: The preparation is contraindicated in patients with severe hepatic (liver) or renal (kidney) impairment, or in those with pre-existing gastrointestinal conditions such as active gastritis, oesophagitis, or gastric/duodenal ulcers.
  • Long-Term Exposure: Prolonged or repeated use is associated with a risk of developing tolerance and physical dependence. Long-term use may also cause serious stomach problems.
  • Population-Specific Notes: Older adults may be more susceptible to central nervous system effects like confusion and unsteadiness (ataxia). Due to limited data and potential risks, the use of the Chloral Hydrate component should not be used during pregnancy or lactation. The medicine is classified as having a greater risk of potentiating sedative effects when co-administered with other CNS depressants.

Overdose and Emergency Response

Overdose and When to Seek Help

Overexposure to Denta's active components, Camphor and Chloral Hydrate, presents a risk of severe systemic toxicity, necessitating immediate emergency action as mandated by regulatory authorities.

Documented Overdose Manifestations

Manifestations officially described in regulatory documents include severe confusion, extreme drowsiness, and neurological excitation progressing to seizures (convulsions) and coma. Documented gastrointestinal effects are abdominal pain, nausea, and vomiting. Life-threatening outcomes include severe cardiac arrhythmias, such as ventricular dysrhythmias, severe hypotension, and acute respiratory depression leading to respiratory arrest. The potential for corrosive injury to the gastrointestinal mucosa is also noted.

Emergency Actions and Required Monitoring

Individuals must seek immediate medical attention for any suspected overdose. Emergency services must be called immediately if the person has collapsed, had a seizure, has severe trouble breathing, or cannot be awakened, as stated in official guidance. Treatment is primarily symptomatic and supportive, as regulatory information confirms that no specific antidote is known for the active components. Official monitoring requirements include continuous cardiac monitoring (ECG) and vital sign observation. Patients are monitored for the risk of re-sedation, which can persist for up to 24 hours. A specific risk of severity is noted for the pediatric population, including the potential for prolonged sedation and respiratory arrest.

Therapeutic Uses of Denta

What Denta Treats: Main Uses and Benefits

The Denta preparation may be part of symptomatic management, supporting localized relief aligned with specific acute and episodic discomfort patterns within the oral cavity. The active components are considered relevant for external analgesic and counterirritant uses.

Denta is primarily relevant in clinical settings that involve acute dental pain (odontalgia) and localized oral discomfort. The preparation is considered relevant for addressing symptom clusters that may become intense or disruptive, such as sharp toothaches and surface irritation. A key benefit may be that it helps provide temporary, surface-level relief and supports comfort during difficult episodes.

This supportive relief may assist with maintaining functional stability when symptoms interfere with routine activities. The therapeutic domains addressed include easing symptoms related to inflammatory or irritative states at the point of application and providing supportive management until definitive professional dental care can be accessed.

Quick Fact

Support for Acute Localized Dental Pain

Eligibility and Restrictions for Use

Denta is officially established for use by adults and children aged 12 years and older. This specific minimum age threshold is mandated in regulatory labeling for this class of topical preparation, with use in children under 12 years of age strictly prohibited or not recommended without professional consultation. Safety and efficacy are generally not established for this younger pediatric population.

Use of the solution is strictly contraindicated for individuals with a known hypersensitivity or allergic reaction to the active ingredient Camphor or any other component in the formulation. Furthermore, regulatory rules dictate that Denta must not be applied to compromised surfaces, including damaged skin, open wounds, serious burns, or areas that are excessively reddened or swollen at the application site.

For populations with reproductive status changes, such as pregnant or breast-feeding women, eligibility is strictly conditional. The official labeling mandates that these individuals must consult a health professional prior to use, as safety has not been unconditionally established in these groups. The preparation is restricted to external application only and must avoid contact with eyes or mucous membranes.

What should I know about interactions with other medicines?

Denta Interactions with other medicines and products

This section details interaction information for Denta (Camphor and Chloral Hydrate solution) as documented in official government regulatory sources, focusing on risks associated with the Chloral Hydrate component's potential for systemic effect.


Pharmacodynamic Interaction Risks

The primary interaction pattern is pharmacodynamic enhancement, which describes an additive or potentiating effect:

  • CNS Depressants: Co-administration with other Central Nervous System (CNS) Depressants (including opioid pain relievers, benzodiazepines, sedative antihistamines, and antipsychotics) may result in an enhancement of the central depressive effect (additive sedation), as documented in prescribing information.
  • Alcohol (Ethanol): Concomitant use with alcohol is documented to potentiate the sedative effect from the Chloral Hydrate component and should be avoided.

Documented Interaction Cautions

Interacting Substance/Condition Officially Documented Constraint
QT-prolonging medicines Co-administration may increase the risk of cardiac arrhythmias (torsades de pointes) [SmPC, Chloral Hydrate].
Intravenous Furosemide Administration following Denta may result in acute effects, including sweating, hot flushes, and variable blood pressure (hypertension) [SmPC, Chloral Hydrate].

Population-Specific Restrictions

Regulatory text specifies that Denta is prohibited (contraindicated) for use in patients with the following conditions due to a significantly heightened risk of systemic toxicity:

  • Severe Hepatic Dysfunction
  • Severe Renal Dysfunction
  • Severe Cardiac Dysfunction
  • Intermittent Hematoporphyria

The overall interaction structure is defined by the requirement to manage the known systemic activity of Chloral Hydrate with co-administered substances, and the inherent toxicity risk in specific compromised populations.

Mechanism of Action

Modulating Neuronal Excitation Pathways

Denta primarily acts within domains involving receptor- or enzyme-mediated signaling by engaging with ion channels on nerve cell membranes. This initiates or suppresses signaling sequences by stabilizing the inactive state of voltage-gated sodium channels, thereby blocking the influx of sodium ions necessary for depolarization and action potential propagation. The resulting physiological effect limits nerve excitation, influencing the systemic physiological outcome by restricting action potential propagation within the targeted neural pathways.

Regulating Local Tissue Mediator Activity

The drug further engages mechanisms that regulate overactive or dysregulated processes by influencing pathways associated with heightened physiological responses in local tissues. This mechanism modulates early molecular steps in inflammatory cascades, such as those involving mediators like prostaglandins. This action reduces the activity profile of excessive mediators, resulting in a modified physiological response at the application site.

Influencing Systemic Absorption Kinetics

Denta is relevant in systems where targeted pathway adjustment is required, often by being paired with a compound that affects the local circulation. By modulating vascular smooth muscle receptors, this additional mechanism influences the rate of drug absorption and distribution away from the application site. This mechanism influences local transmitter or mediator activity by restricting Denta's distribution, thereby confining the primary action to the localized area and maintaining pathway modulation.

Dosage and Administration Information

How Denta is Used: Official Administration Guidelines

The Denta preparation, containing Camphor and Chloral Hydrate, is strictly indicated for topical and external use only, consistent with the classification of its components for external application. The official use is confined to providing temporary relief and is not intended for long-term administration or systemic treatment. This section describes the standardized approach to its use.


Administration Scope

Instruction Detail
Route of administration Topical (External use only).
Dosing schedule (official) Appropriate amount each time, sufficient to saturate the application material.
Frequency pattern As-needed (p.r.n.), up to several times a day.
Special procedural condition Strictly prohibited for internal consumption.
Age-group administration Use with caution in children.

Official Application Procedure

The administration of Denta involves a specific procedural technique rather than a fixed volumetric measure, reflecting its targeted application. The solution is typically applied by following a sequence of steps:

  • Obtain the necessary amount of solution for a single application.
  • Saturate a cotton wool swab or similar material with the liquid preparation.
  • Apply the saturated material directly to the painful surface or affected area within the oral cavity.

This application is for short-term symptomatic management only, defining its function as a time-bound measure before definitive professional care. The procedural instructions mandate that the solution must only be used externally, ensuring the intended local anesthetic and antiseptic action is focused solely at the site of discomfort.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Denta


I. Evidence for Use in Acute Dental Pain and Localized Discomfort

The active components in the Denta preparation have been studied for their use in scenarios focusing on temporary, symptomatic management of acute dental pain (odontalgia) and localized oral discomfort. The existing research focuses on the classification of the ingredients as a local anesthetic and antiseptic, a combination applied in studies examining short-term or episodic symptom patterns. This body of work primarily includes pharmacological studies documented within the clinical dentistry literature, alongside supporting regulatory documentation that references the external analgesic and counterirritant uses of the active components.

Studies research examined the application of this preparation on the surface, focusing on how it might influence sensory nerves to address localized comfort. The research describes that the preparation was observed in a scenario focusing on supportive measure use during immediate, acute symptoms while the patient is awaiting necessary professional procedures.


II. Outcomes Measured in Clinical Dentistry Research

Outcomes examined in studies included the reported change in localized discomfort over defined, short time intervals, as well as measures related to outcomes reflecting daily functioning or activity level during episodes where acute symptoms interfere with routine activities. Investigators monitored outcomes related to physical discomfort, including the occurrence of a localized analgesic effect, which research describes as being related to the desensitization of nerve endings at the treatment site.

The findings data show patterns related to very fast, localized action. The patient-reported outcomes describing perceived discomfort were central to understanding the preparation's temporary role. However, the evidence is not designed to explore long-term pain control or the progression of the underlying dental condition.


III. Understanding the Research Scope and Limitations

The overall evidence for Denta contributes to the broader evidence landscape concerning short-term symptom management. Since Denta is studied for its role in providing immediate, temporary relief, the follow-up durations were limited in the existing evidence base. Long-term effects are not fully established because the preparation is not intended for chronic use.

The research describes Denta as a preparation intended for use as a supportive measure. Comparative evidence is lacking regarding studies that examined Denta alongside a control or other temporary surface anesthetics. Therefore, research provides context but not individual predictions, and the evidence highlights what is known—and what is still uncertain—about its use in temporary pain management.

Frequently Asked Questions (FAQ)

Common questions about Denta (FAQ)


Q: How quickly does Denta usually start to work?

A: Studies and official information indicate that Denta is intended to provide a fast-acting, localized analgesic effect. The preparation is intended to provide temporary relief by exerting this effect at the application site. Since the preparation is for short-term, symptomatic use, its primary purpose is to quickly address acute discomfort.


Q: How long does the effect of Denta typically last?

A: The preparation is primarily intended for short-term, temporary symptomatic management of discomfort. Due to this intent, research follow-up durations for the localized effect were generally limited. It is not designed or intended for long-term or chronic use.


Q: Can Denta affect my ability to drive or operate machinery?

A: Official labeling for the components states that this medicine may impair a user's thinking or reactions. Official labeling indicates caution should be exercised when performing tasks that require mental alertness, such as driving or operating heavy machinery, due to the potential for central nervous system effects like dizziness or drowsiness.


Q: Does Denta need to be taken with food?

A: Denta is a topical solution for external use. However, for the Chloral Hydrate component, when administered orally in other contexts, it is sometimes recommended to be taken with food or milk. This recommendation is documented to potentially mitigate the possibility of stomach upset, as noted in drug information.


Q: Can elderly patients use Denta?

A: Official safety constraints state that older adults may be more susceptible to central nervous system effects. These effects include confusion and unsteadiness, which is also known as ataxia. Such changes carry a potential to increase the risk of falling. Specific caution is noted in regulatory documents regarding use in this population.


Q: Is Denta a controlled substance?

A: The Chloral Hydrate component of Denta is federally classified as a Schedule IV controlled substance. This official classification is used to categorize substances with a low potential for abuse and a low risk of dependence relative to other controlled substances.


Q: What happens if Denta is stopped suddenly?

A: Official warnings note that prolonged or repeated use is associated with a risk of developing tolerance and physical dependence. If the preparation has been used long-term, official guidance indicates the need to discuss cessation with a health professional.


Q: Is Denta available over the counter, or do I need a prescription?

A: The Denta preparation is classified by regulatory authorities as a prescription drug. This means it is available through a licensed pharmacy and requires a valid prescription from a qualified healthcare professional.


Q: Can Denta be crushed or split in half?

A: Denta is supplied as a liquid solution for external, topical application. Since it is a liquid, this preparation is not a tablet or capsule that can be crushed or split.


Q: Does Denta need any special monitoring while being used?

A: The official prescribing information for the systemic component suggests that patients with a history of heart, kidney, or liver disease may require careful monitoring for side effects. This is due to the potential for systemic absorption of the ingredients.


Q: What evidence exists about Denta's effectiveness in different age groups?

A: Official regulatory labeling mandates a minimum age threshold for this class of topical preparation. Efficacy is established for adults and children aged 12 years and older. The safety and effectiveness of the preparation are not established for children under 12 years of age.


Q: Is it true that Denta can cause changes in mood?

A: Documented adverse reactions for the systemic component of Denta include potential mental or mood changes. These reported changes can include feelings of confusion.


Q: Is Denta a habit-forming drug?

A: Official warnings indicate that prolonged or repeated use carries a risk of developing physical dependence and tolerance. The preparation is only intended for short-term management, and caution regarding potential dependence is noted in regulatory documents.


Q: What should I do if my side effects from Denta do not go away?

A: Regulatory guidance describes that patients should contact a health professional immediately if side effects are severe, persistent, or serious. Serious effects could include signs of kidney problems or a severe rash. Patients are also encouraged to report adverse events to the relevant government authority.


Q: Is Denta recommended for people with heart conditions?

A: The preparation is strictly prohibited (contraindicated) for use in patients with Severe Cardiac Dysfunction. Patients with heart disease are directed to consult a health professional prior to use, as the Chloral Hydrate component carries specific cardiac warnings.


Q: Can I use Denta if I am allergic to similar medications?

A: Official labeling states the preparation is contraindicated for individuals with a known hypersensitivity or allergic reaction to the active ingredient Camphor or any other component in the formulation.


Q: What happens if I accidentally miss a dose of Denta?

A: Denta is intended for use as needed for temporary relief. If a user is following a specific schedule and misses an application, the general regulatory approach for scheduled doses is to skip the missed application and resume the schedule. Regulatory information indicates that two applications should not be made at once.


Q: What are the potential systemic risks of Denta?

A: Though intended for topical use, the Chloral Hydrate component carries official warnings regarding potential systemic risks if absorbed. These serious risks include effects on the cardiac system (such as arrhythmias), respiratory depression, and severe central nervous system effects.

How should Denta be stored and disposed of?

How to Store and Dispose of Denta Solution

The storage and disposal of Denta solution (Camphor/Chloral Hydrate) must strictly follow official regulatory mandates to ensure stability and safety.


Storage Requirements

  • Temperature: Store at Controlled Room Temperature, typically 20 C to 25 C. The solution must not be frozen.
  • Protection: Keep the medication in its original container, tightly closed, and protect from light and excessive heat.
  • Child Safety: Store this medication out of the sight and reach of children and away from ignition sources.

Disposal Instructions

  • Disposal: Unused or expired Denta must be discarded through a community drug take-back program or according to specific local regulated waste procedures.
  • Restriction: Do not pour the solution down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Denta found in:

A-Z Index: